Clinical Trial Update: An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients [NA]

View source ↗

Summary

An open-label exploratory study in newly diagnosed prostate cancer patients is noted, with the trial status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Prostatic Neoplasms | NA | Status: COMPLETED